Search research articles
Contact Us
Filters
Showing results (441-450 of 4,125) with videos related to
Page
of 413
Sort By:
Inorganic Chemistry
|
June 24, 2009
Infrared spectra and density functional calculations of the SUO2 molecule
Xuefeng Wang, Lester Andrews, Colin J Marsden
Methods in Molecular Biology (Clifton, N.J.)
|
May 5, 2017
N- and C-Terminal Truncations to Enhance Protein Solubility and Crystallization: Predicting Protein Domain Boundaries with Bioinformatics Tools
Christopher D O Cooper, Brian D Marsden
Clinical Laboratory Science : Journal of the American Society for Medical Technology
|
August 6, 2008
Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
European Journal of Pharmacology
|
January 1, 1976
Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase
A Dolphin, P Jenner, C D Marsden
The British Journal of Dermatology
|
December 1, 1988
Linear IgA dermatosis with severe arthralgia
G Leigh, R A Marsden, F Wojnarowska
British Journal of Clinical Pharmacology
|
January 1, 1983
Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease
P Jenner, M Sheehy, C D Marsden
Ciba Foundation Symposium
|
January 1, 1984
Gamma-aminobutyric acid and basal ganglia outflow pathways
C Reavill, P Jenner, C D Marsden
Neuropharmacology
|
December 1, 1982
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems
G Luscombe, P Jenner, C D Marsden
European Journal of Pharmacology
|
August 15, 1979
Changes in dopamine-mediated behaviour during one year's neuroleptic administration
A Clow, P Jenner, C D Marsden
Seminars in Thrombosis and Hemostasis
|
May 9, 2012
Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
Page
of 413
Search research articles
Search
Showing results (441-450 of 4,125) with videos related to
Sort By:
Page
of 413
Inorganic Chemistry
|
June 24, 2009
Infrared spectra and density functional calculations of the SUO2 molecule
Xuefeng Wang, Lester Andrews, Colin J Marsden
Methods in Molecular Biology (Clifton, N.J.)
|
May 5, 2017
N- and C-Terminal Truncations to Enhance Protein Solubility and Crystallization: Predicting Protein Domain Boundaries with Bioinformatics Tools
Christopher D O Cooper, Brian D Marsden
Clinical Laboratory Science : Journal of the American Society for Medical Technology
|
August 6, 2008
Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
European Journal of Pharmacology
|
January 1, 1976
Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase
A Dolphin, P Jenner, C D Marsden
The British Journal of Dermatology
|
December 1, 1988
Linear IgA dermatosis with severe arthralgia
G Leigh, R A Marsden, F Wojnarowska
British Journal of Clinical Pharmacology
|
January 1, 1983
Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease
P Jenner, M Sheehy, C D Marsden
Ciba Foundation Symposium
|
January 1, 1984
Gamma-aminobutyric acid and basal ganglia outflow pathways
C Reavill, P Jenner, C D Marsden
Neuropharmacology
|
December 1, 1982
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems
G Luscombe, P Jenner, C D Marsden
European Journal of Pharmacology
|
August 15, 1979
Changes in dopamine-mediated behaviour during one year's neuroleptic administration
A Clow, P Jenner, C D Marsden
Seminars in Thrombosis and Hemostasis
|
May 9, 2012
Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
Page
of 413